Ageing Research Reviews,
Journal Year:
2020,
Volume and Issue:
60, P. 101072 - 101072
Published: April 14, 2020
Cardiovascular
disease
(CVD)
is
the
most
common
to
increase
as
life
expectancy
increases.
Most
high-profile
pharmacological
treatments
for
age-related
CVD
have
led
inefficacious
results,
implying
that
novel
approaches
treating
these
pathologies
are
needed.
Emerging
data
demonstrated
senescent
cardiovascular
cells,
which
characterized
by
irreversible
cell
cycle
arrest
and
a
distinct
senescence-associated
secretory
phenotype,
accumulate
in
aged
or
diseased
systems,
suggesting
they
may
impair
function.
This
review
discusses
evidence
implicating
cells
ageing,
onset
progression
of
CVD,
molecular
mechanisms
underlying
senescence.
We
also
eradication
small-molecule-drug-mediated
apoptosis
immune
cell-mediated
efferocytosis
toxicity
promising
precisely
targeted
therapeutics
prevention
treatment.
Cardiovascular Research,
Journal Year:
2021,
Volume and Issue:
118(5), P. 1173 - 1187
Published: May 5, 2021
Abstract
Cellular
senescence
is
a
state
of
irreversible
cell
cycle
arrest
associated
with
ageing.
Senescence
different
cardiac
types
can
direct
the
pathophysiology
cardiovascular
diseases
(CVDs)
such
as
atherosclerosis,
myocardial
infarction,
and
fibrosis.
While
age-related
telomere
shortening
represents
major
cause
replicative
senescence,
senescent
also
be
induced
by
oxidative
stress,
metabolic
dysfunction,
epigenetic
regulation,
among
other
stressors.
It
critical
that
we
understand
molecular
pathways
lead
to
cellular
consequences
in
order
develop
new
therapeutic
approaches
treat
CVD.
In
this
review,
discuss
mechanisms
explore
how
(including
cardiomyocytes,
endothelial
cells,
fibroblasts,
vascular
smooth
muscle
valve
interstitial
cells)
CVD,
highlight
potential
target
prevent
or
Frontiers in Endocrinology,
Journal Year:
2020,
Volume and Issue:
11
Published: May 21, 2020
Cardiovascular
diseases
have
become
the
leading
cause
of
human
death.
Aging
is
an
independent
risk
factor
for
cardiovascular
diseases.
Cardiac
aging
associated
with
maladaptation
cellular
metabolism,
dysfunction
(or
senescence)
cardiomyocytes,
a
decrease
in
angiogenesis,
and
increase
tissue
scarring
(fibrosis).
These
events
eventually
lead
to
cardiac
remodeling
failure.
Senescent
cardiomyocytes
show
hallmarks
DNA
damage,
endoplasmic
reticulum
stress,
mitochondria
dysfunction,
contractile
hypertrophic
growth,
senescence-associated
secreting
phenotype
(SASP).
Metabolism
within
essential
not
only
fuel
pump
function
heart
but
also
maintain
functional
homeostasis
participate
senescence
cardiomyocytes.
The
cardiomyocyte
regulated
by
non-myocytes
(endothelial
cells,
fibroblasts,
immune
cells)
local
microenvironment.
On
other
hand,
senescent
alter
their
phenotypes
subsequently
affect
microenvironment
contribute
pathological
remodeling.
In
this
review,
we
first
summarized
Then,
discussed
metabolic
switch
provided
discussion
communications
between
dysfunctional
We
addressed
functions
regulators
modulating
myocardial
Finally,
pointed
out
some
interesting
important
questions
that
are
needed
be
further
studies.
Cells,
Journal Year:
2020,
Volume and Issue:
9(3), P. 671 - 671
Published: March 10, 2020
Senescent
cells
are
generally
characterized
by
permanent
cell
cycle
arrest,
metabolic
alteration
and
activation,
apoptotic
resistance
in
multiple
organs
due
to
various
stressors.
Excessive
accumulation
of
senescent
numerous
tissues
leads
chronic
diseases,
tissue
dysfunction,
age-related
diseases
organ
ageing.
Immune
can
remove
cells.
Immunaging
or
impaired
innate
adaptive
immune
responses
result
persistent
Although
senolytics—drugs
that
selectively
inducing
their
apoptosis—are
recent
hot
topics
making
significant
research
progress,
senescence
immunotherapies
using
cell-mediated
clearance
emerging
promising
strategies
fight
ageing
diseases.
This
short
review
provides
an
overview
the
progress
date
concerning
cell-caused
ageing,
as
well
regulation
small-molecule
drugs
clinical
trials
different
roles
elimination
Mounting
evidence
indicates
immunotherapy
targeting
combats
subsequently
extends
healthy
lifespan.
Nature Communications,
Journal Year:
2023,
Volume and Issue:
14(1)
Published: March 10, 2023
Vascular
endothelial
cells
(ECs)
senescence
correlates
with
the
increase
of
cardiovascular
diseases
in
ageing
population.
Although
ECs
rely
on
glycolysis
for
energy
production,
little
is
known
about
role
senescence.
Here,
we
report
a
critical
glycolysis-derived
serine
biosynthesis
preventing
During
senescence,
expression
biosynthetic
enzyme
PHGDH
significantly
reduced
due
to
decreased
transcription
activating
factor
ATF4,
which
leads
reduction
intracellular
serine.
prevents
premature
primarily
by
enhancing
stability
and
activity
pyruvate
kinase
M2
(PKM2).
Mechanistically,
interacts
PKM2,
PCAF-catalyzed
PKM2
K305
acetylation
subsequent
degradation
autophagy.
In
addition,
facilitates
p300-catalyzed
K433
acetylation,
promotes
nuclear
translocation
stimulates
its
phosphorylate
H3T11
regulate
senescence-associated
genes.
endothelium-targeted
ameliorates
mice.
Our
findings
reveal
that
could
become
therapy
promote
healthy
ageing.
Cell Death Discovery,
Journal Year:
2024,
Volume and Issue:
10(1)
Published: Feb. 14, 2024
Abstract
Cardiac
aging,
particularly
cardiac
cell
senescence,
is
a
natural
process
that
occurs
as
we
age.
Heart
function
gradually
declines
in
old
age,
leading
to
continuous
heart
failure,
even
people
without
prior
history
of
disease.
To
address
this
issue
and
improve
function,
it
crucial
investigate
the
molecular
mechanisms
underlying
senescence.
This
review
summarizes
main
key
proteins
involved
further
discusses
modulators
cellular
senescence
aging
hearts.
Furthermore,
discussion
will
encompass
comprehensive
descriptions
drugs,
modes
action
potential
targets
for
intervention
By
offering
fresh
perspective
insights
into
seeks
provide
important
theoretical
foundations
development
drugs
targeting
condition.
Oxidative Medicine and Cellular Longevity,
Journal Year:
2020,
Volume and Issue:
2020, P. 1 - 20
Published: May 9, 2020
The
global
population
above
60
years
has
been
growing
exponentially
in
the
last
decades,
which
is
accompanied
by
an
increase
prevalence
of
age-related
chronic
diseases,
highlighting
cardiovascular
diseases
(CVDs),
such
as
hypertension,
atherosclerosis,
and
heart
failure.
Aging
main
risk
factor
for
these
diseases.
Such
susceptibility
to
disease
explained,
at
least
part,
oxidative
stress,
it
damages
cellular
components
proteins,
DNA,
lipids.
In
addition,
inflammatory
process
aging
“inflammaging”
also
contributes
cell
damage,
creating
a
stressful
environment
drives
development
CVDs.
Taken
together,
possible
identify
molecular
connection
between
stress
process,
especially
crosstalk
transcription
factors
Nrf-2
NF-
κ
B
are
mediated
redox
signalling
involved
aging.
Therapies
that
control
this
key
targets
prevention/combat
review,
we
show
basics
inflammation
including
them,
implications
on
Cell Research,
Journal Year:
2020,
Volume and Issue:
31(4), P. 415 - 432
Published: Sept. 10, 2020
Aging
is
a
major
risk
factor
for
many
diseases,
especially
in
highly
prevalent
cardiopulmonary
comorbidities
and
infectious
diseases
including
Coronavirus
Disease
2019
(COVID-19).
Resolving
cellular
molecular
mechanisms
associated
with
aging
higher
mammals
therefore
urgently
needed.
Here,
we
created
young
old
non-human
primate
single-nucleus/cell
transcriptomic
atlases
of
lung,
heart
artery,
the
top
tissues
targeted
by
SARS-CoV-2.
Analysis
cell
type-specific
aging-associated
transcriptional
changes
revealed
increased
systemic
inflammation
compromised
virus
defense
as
hallmark
aging.
With
age,
expression
SARS-CoV-2
receptor
angiotensin-converting
enzyme
2
(ACE2)
was
pulmonary
alveolar
epithelial
barrier,
cardiomyocytes,
vascular
endothelial
cells.
We
found
that
interleukin
7
(IL7)
accumulated
aged
induced
ACE2
human
cells
an
NF-κB-dependent
manner.
Furthermore,
treatment
vitamin
C
blocked
IL7-induced
expression.
Altogether,
our
findings
depict
first
atlas
system
provide
vital
insights
into
age-linked
susceptibility
to
SARS-CoV-2,
suggesting
geroprotective
strategies
may
reduce
COVID-19
severity
elderly.
Circulation Research,
Journal Year:
2020,
Volume and Issue:
126(4), P. 533 - 551
Published: Feb. 13, 2020
During
aging,
deterioration
in
cardiac
structure
and
function
leads
to
increased
susceptibility
heart
failure.
The
need
for
interventions
combat
this
age-related
decline
is
becoming
increasingly
urgent
as
the
elderly
population
continues
grow.
Our
understanding
of
aging
general,
limited.
However,
recent
studies
its
prevention
through
like
exercise
have
revealed
novel
pathological
cardioprotective
pathways.
In
review,
we
summarize
findings
concerning
molecular
mechanisms
failure
highlight
a
valuable
experimental
platform
discovery
much-needed
therapeutic
targets
chronic
disease.